Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role and Function of O-GlcNAcylation in Cancer.
Lee JB, Pyo KH, Kim HR. Lee JB, et al. Among authors: kim hr. Cancers (Basel). 2021 Oct 26;13(21):5365. doi: 10.3390/cancers13215365. Cancers (Basel). 2021. PMID: 34771527 Free PMC article. Review.
Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma.
Kim HS, Kim SM, Kim H, Pyo KH, Sun JM, Ahn MJ, Park K, Keam B, Kwon NJ, Yun HJ, Kim HG, Chung IJ, Lee JS, Lee KH, Kim DJ, Lee CG, Hur J, Chung H, Park JC, Shin SK, Lee SK, Kim HR, Moon YW, Lee YC, Kim JH, Paik S, Cho BC. Kim HS, et al. Among authors: kim hg, kim h, kim dj, kim sm, kim hr, kim jh. Oncotarget. 2015 Dec 29;6(42):44971-84. doi: 10.18632/oncotarget.6056. Oncotarget. 2015. PMID: 26462025 Free PMC article. Clinical Trial.
Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.
Yun MR, Lim SM, Kim SK, Choi HM, Pyo KH, Kim SK, Lee JM, Lee YW, Choi JW, Kim HR, Hong MH, Haam K, Huh N, Kim JH, Kim YS, Shim HS, Soo RA, Shih JY, Yang JC, Kim M, Cho BC. Yun MR, et al. Among authors: kim sk, kim m, kim hr, kim ys, kim jh. Cancer Res. 2018 Jun 15;78(12):3350-3362. doi: 10.1158/0008-5472.CAN-17-3146. Epub 2018 Apr 18. Cancer Res. 2018. PMID: 29669761
Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
Kang HN, Choi JW, Shim HS, Kim J, Kim DJ, Lee CY, Hong MH, Park SY, Park AY, Shin EJ, Lee SY, Pyo KH, Yun MR, Choi HM, Lee SS, Kim SY, Lee H, Paik S, Cho BC, Lee JG, Kim HR. Kang HN, et al. Among authors: kim dj, kim sy, kim hr, kim j. Lung Cancer. 2018 Oct;124:168-178. doi: 10.1016/j.lungcan.2018.08.008. Epub 2018 Aug 11. Lung Cancer. 2018. PMID: 30268457
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice.
Ahn BC, Pyo KH, Xin CF, Jung D, Shim HS, Lee CY, Park SY, Yoon HI, Hong MH, Cho BC, Kim HR. Ahn BC, et al. Among authors: kim hr. J Cancer Res Clin Oncol. 2019 Jun;145(6):1613-1623. doi: 10.1007/s00432-019-02899-y. Epub 2019 Mar 25. J Cancer Res Clin Oncol. 2019. PMID: 30911841 Free PMC article.
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer.
Yun MR, Choi HM, Lee YW, Joo HS, Park CW, Choi JW, Kim DH, Kang HN, Pyo KH, Shin EJ, Shim HS, Soo RA, Yang JC, Lee SS, Chang H, Kim MH, Hong MH, Kim HR, Cho BC. Yun MR, et al. Among authors: kim dh, kim hr, kim mh. EMBO Mol Med. 2019 Dec;11(12):e10581. doi: 10.15252/emmm.201910581. Epub 2019 Oct 21. EMBO Mol Med. 2019. PMID: 31633304 Free PMC article.
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
Kang HN, Kim JH, Park AY, Choi JW, Lim SM, Kim J, Shin EJ, Hong MH, Pyo KH, Yun MR, Kim DH, Lee H, Yoon SO, Kim DH, Park YM, Byeon HK, Jung I, Paik S, Koh YW, Cho BC, Kim HR. Kang HN, et al. Among authors: kim dh, kim hr, kim j, kim jh. BMC Cancer. 2020 Apr 15;20(1):316. doi: 10.1186/s12885-020-06786-5. BMC Cancer. 2020. PMID: 32293356 Free PMC article.
3,227 results